Narayana Health has reported robust growth for the fiscal year ended March 31, 2026. The company achieved consolidated revenue of ₹81,344.74 million and a net profit after tax of ₹8,059.79 million for the year. Following this performance, the Board of Directors has recommended a final dividend of ₹4.50 per share. Additionally, the company is seeking shareholder approval to raise up to ₹1,500 crore via debt securities to support future growth initiatives.
Financial Highlights for Fiscal Year 2026
Narayana Health concluded the financial year ended March 31, 2026, with significant financial growth. The company reported a consolidated annual revenue of ₹81,344.74 million, compared to ₹57,104.37 million in the previous fiscal year. Consolidated net profit for the year stood at ₹8,059.79 million, showing continued operational strength and expansion.
Dividend and Annual General Meeting
In light of the strong fiscal results, the Board of Directors has recommended a final dividend of ₹4.50 per share. The record date for determining shareholder eligibility for the dividend has been set for Friday, July 17, 2026. Furthermore, the 26th Annual General Meeting is scheduled to take place on Friday, August 14, 2026, via video conferencing.
Strategic Growth and Capital Raising
To support its ongoing expansion and operational needs, the Board has resolved to seek shareholder approval for an enabling resolution to issue debt securities, including non-convertible debentures, for an amount not exceeding ₹1,500 crore in a financial year. This capital raise is intended to be executed on a private placement basis in one or more tranches.
Leadership Update
The company announced the re-appointment of Ms. Terri Smith Bresenham as an Independent Director for a second five-year term, effective August 5, 2026, through August 4, 2031. Ms. Bresenham is a recognized healthcare innovator with extensive global experience in digital health and clinical data platforms.
Source: BSE
